Navarrete, J, Colomer-Carbonell, A, Sanabria-Mazo, JP, Luciano, JV, Soler, J, Garcia-Campayo, J, Demarzo, M, Montero-Marin, J, Bohlmeijer, ET, Campos, D, Cebolla, A, Feliu-Soler, A. Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims. Journal of Contextual Behavioral Science. 2023; 28DOI:10.1016/j.jcbs.2023.05.001. PMID:. IF:3.400(Q1/2D).

Cano, M, Camprodon, JA. Understanding the Mechanisms of Action of Electroconvulsive Therapy Revisiting Neuroinflammatory and Neuroplasticity Hypotheses. JAMA Psychiatry. 2023; 80(6)DOI:10.1001/jamapsychiatry.2023.0728. PMID:37074712. IF:22.500(Q1/1D).

Nunez, C, Garcia-Alix, A, Arca, G, Agut, T, Carreras, N, Portella, MJ, Stephan-Otto, C. Breastfeeding duration is associated with larger cortical gray matter volumes in children from the ABCD study. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2023; 64(7)DOI:10.1111/jcpp.13790. PMID:36946606. IF:6.500(Q1/1D).

Verdolini, N, Mezquida, G, Valli, I, Garcia-Rizo, C, Cuesta, M, Vieta, E, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Pina-Camacho, L, Corripio, I, Garriga, M, Baeza, I, Martinez-Sadurni, L, Bitanihirwe, B, Cannon, M, Bernardo, M. Obstetric complications and clinical presentation in first episode of psychosis. ACTA NEUROPSYCHIATRICA. 2023; DOI:10.1017/neu.2023.9. PMID:36861430. IF:3.800(Q2/5D).

García-Campayo J., Hijar-Aguinaga R., López-Del-Hoyo Y., Magallón-Botaya R., Fernández-Martínez S., Barceló-Soler A., Soler-Ribaudi J., Montero-Marin J.. Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial. Trials. 2023; 24(1)DOI:10.1186/s13063-023-07151-0. PMID:36805694. IF:2.000(Q3/7D).

Florido, A, Velasco, ER, Monari, S, Cano, M, Cardoner, N, Sandi, C, Andero, R, Perez-Caballero, L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4.600(Q1/2D).

Sanchez-Torres, AM, Amoretti, S, Enguita-German, M, Mezquida, G, Moreno-Izco, L, Panadero-Gomez, R, Rementeria, L, Toll, A, Rodriguez-Jimenez, R, Roldan, A, Pomarol-Clotet, E, Ibanez, A, Usall, J, Contreras, F, Vieta, E, Lopez-Ilundain, JM, Merchan-Naranjo, J, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Cuesta, MJ. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 67DOI:10.1016/j.euroneuro.2022.11.011. PMID:36495858. IF:6.100(Q1/1D).

Porta-Casteràs D., Cano M., Navarra-Ventura G., Serra-Blasco M., Vicent-Gil M., Solé B., Montejo L., Torrent C., Martinez-Aran A., Harrison B.J., Palao D., Vieta E., Cardoner N.. Disrupted network switching in euthymic bipolar disorder: Working memory and self-referential paradigms. JOURNAL OF AFFECTIVE DISORDERS. 2023; 320DOI:10.1016/j.jad.2022.09.152. PMID:36202301. IF:4.900(Q1/2D).

Lin, BD, Pinzon-Espinosa, J, Blouzard, E, van der Horst, MZ, Okhuijsen-Pfeifer, C, van Eijk, KR, Guloksuz, S, Peyrot, WJ, Luykx, JJ. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA Psychiatry. 2023; 80(2)DOI:10.1001/jamapsychiatry.2022.4234. PMID:36542388. IF:22.500(Q1/1D).

Blanken M.A.J.T., Oudega M.L., Hoogendoorn A.W., Sonnenberg C.S., Rhebergen D., Klumpers U.M.H., Van Diermen L., Birkenhager T., Schrijvers D., Redlich R., Dannlowski U., Heindel W., Coenjaerts M., Nordanskog P., Oltedal L., Kessler U., Frid L.M., Takamiya A., Kishimoto T., Jorgensen M.B., Jorgensen A., Bolwig T., Emsell L., Sienaert P., Bouckaert F., Abbott C.C., Péran P., Arbus C., Yrondi A., Kiebs M., Philipsen A., van Waarde J.A., Prinsen E., van Verseveld M., Van Wingen G., ten Doesschate F., Camprodon J.A., Kritzer M., Barbour T., Argyelan M., Cardoner N., Urretavizcaya M., Soriano-Mas C., Narr K.L., Espinoza R.T., Prudic J., Rowny S., van Eijndhoven P., Tendolkar I., Dols A.. Sex-specifics of ECT outcome. JOURNAL OF AFFECTIVE DISORDERS. 2023; 326DOI:10.1016/j.jad.2022.12.144. PMID:36632848. IF:4.900(Q1/2D).

Sastre-Buades A., Caro-Cañizares I., Ochoa S., Lorente-Rovira E., Barajas A., Gutiérrez-Zotes A., Sánchez-Alonso S., López-Carrilero R., Grasa E., Pousa E., Pélaez T., Cid J., González-Higueras F., Ruiz-Delgado I., Baca-Garcia E., Barrigon M.L.. Relationship between cognition and suicidal behavior in recent-onset psychosis. SCHIZOPHRENIA RESEARCH. 2023; 252DOI:10.1016/j.schres.2022.12.042. PMID:36652834. IF:3.600(Q1/3D).

Gutiérrez F., Aluja A., Rodríguez C., Gárriz M., Peri J.M., Gallart S., Calvo N., Ferrer M., Gutiérrez-Zotes A., Soler J., Pascual J.C.. Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample. Frontiers in Psychiatry. 2023; 13DOI:10.3389/fpsyt.2022.1015489. PMID:36699492. IF:3.200(Q2/4D).

Grasa, E, Seppala, J, Alonso-Solis, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazan, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Usall, J, Ochoa, S, van der Graaf, S, Jewell, C, Triantafillou, A, Stevens, M, Reixach, E, Berdun, J, m RESIST Grp, Corripio, I. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. Jmir Formative Research. 2023; 7DOI:10.2196/46179. PMID:37389933. IF:(Q/D).

Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).

Segal A., Parkes L., Aquino K., Kia S.M., Wolfers T., Franke B., Hoogman M., Beckmann C.F., Westlye L.T., Andreassen O.A., Zalesky A., Harrison B.J., Davey C.G., Soriano-Mas C., Cardoner N., Tiego J., Yücel M., Braganza L., Suo C., Berk M., Cotton S., Bellgrove M.A., Marquand A.F., Fornito A.. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21.300(Q1/1D).

Trujols J., Vicent-Gil M., Duran-Sindreu S., Portella M.J.. A truly patient-centred evaluation of opioid agonist treatment. LANCET PSYCHIATRY. 2023; 10(8)DOI:10.1016/S2215-0366(23)00202-X. PMID:37479338. IF:(Q/D).

Schmidt C., Briones-Buixassa L., Nicolaou S., Soler J., Pascual J.C., Vega D.. Non-suicidal self-injury in young adults with and without borderline personality disorder: the role of emotion dysregulation and negative urgency. Anales de Psicologia. 2023; 39(3)DOI:10.6018/analesps.492631. PMID:. IF:1.400(Q3/8D).

Navarrete J., Fontana-McNally M., Colomer-Carbonell A., Sanabria-Mazo J.P., Pinazo D., Silvestre-López A.-J., Lau M., Tanay G., García-Campayo J., Demarzo M., Soler J., Cebolla A., Feliu-Soler A., Luciano J.V.. The Toronto Mindfulness Scale and the State Mindfulness Scale: psychometric properties of the Spanish versions. Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1212036. PMID:37484107. IF:2.600(Q2/3D).

Ruiz-Delgado, I, Moreno-Kuestner, B, Garcia-Medina, M, Barrigon, ML, Gonzalez-Higueras, F, Lopez-Carrilero, R, Barrios-Mellado, I, Barajas, A, Pousa, E, Lorente-Rovira, E, Grasa, E, Cid, J, Barrau-Sastre, P, Moritz, S, Ochoa, S, Spanish Metacognition Group. Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?. PSYCHIATRY RESEARCH. 2022; 318DOI:10.1016/j.psychres.2022.114941. PMID:36375331. IF:11.300(Q1/1D).

Erausquin J.T., Sánchez J., Yu Pon A., Jhangimal M., Millender E., Peña Y., Ng W., Reina A., Nakad C., Quintana J., Herrera Veces R., Vistica G., Pinzón-Espinosa J., Cabezas-Talavero G., Katz J., Pascale J.M., Rodríguez-Álvarez F., Gabster A.. Sexual and reproductive health and access: Results of a rapid epidemiological assessment among migrant peoples in transit through Darién, Panamá. Frontiers In Reproductive Health. 2022; 4DOI:10.3389/frph.2022.953979. PMID:36523789. IF:(Q/D).

Mendoza-Garcia, S, Garcia-Mieres, H, Lopez-Carrilero, R, Sevilla-Lewellyn-Jones, J, Birules, I, Barajas, A, Lorente-Rovira, E, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Montserrat, R, Martin-Inigo, L, Moreno-Kustner, B, Vila-Bbadia, R, Diaz-Cutraro, L, Verdaguer-Rodriguez, M, Ferrer-Quintero, M, Punsoda-Puche, P, Barrau-Sastre, P, Moritz, S, Ochoa, S. Influence of Maternal and Paternal History of Mental Health in Clinical, Social Cognition and Metacognitive Variables in People with First-Episode Psychosis. Journal of Personalized Medicine. 2022; 12(10)DOI:10.3390/jpm12101732. PMID:36294871. IF:3.508(Q2/4D).

Cuesta, MJ, Ballesteros, A, Sanchez-Torres, AM, Amoretti, S, Lopez-Ilundain, JM, Merchan-Naranjo, J, Gonzalez-Ortega, I, Salgado, P, Rodriguez-Jimenez, R, Roldan-Bejarano, A, Sarro, S, Ibanez, A, Usall, J, Escarti, MJ, Moreno-Izco, L, Mezquida, G, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden. SCHIZOPHRENIA RESEARCH. 2022; 248DOI:10.1016/j.schres.2022.09.014. PMID:36155307. IF:4.500(Q2/4D).

Cano, M, Lee, E, Worthley, A, Ellard, K, Barbour, T, Soriano-Mas, C, Camprodon, JA. Electroconvulsive therapy effects on anhedonia and reward circuitry anatomy: A dimensional structural neuroimaging approach. JOURNAL OF AFFECTIVE DISORDERS. 2022; 313DOI:10.1016/j.jad.2022.06.062. PMID:35764228. IF:6.600(Q1/2D).

Whittle, S, Rakesh, D, Schmaal, L, Veltman, DJ, Thompson, PM, Singh, A, Gonul, AS, Aleman, A, Demir, AU, Krug, A, Mwangi, B, Kramer, B, Baune, BT, Stein, DJ, Grotegerd, D, Pomarol-Clotet, E, Rodriguez-Cano, E, Melloni, E, Benedetti, F, Stein, F, Grabe, HJ, Volzke, H, Gotlib, IH, Nenadic, I, Soares, JC, Repple, J, Sim, K, Brosch, K, Wittfeld, K, Berger, K, Hermesdorf, M, Portella, MJ, Sacchet, MD, Wu, MJ, Opel, N, Groenewold, NA, Gruber, O, Fuentes-Claramonte, P, Salvador, R, Goya-Maldonado, R, Sarro, S, Poletti, S, Meinert, SL, Kircher, T, Dannlowski, U, Pozzi, E. The Role of Educational Attainment and Brain Morphology in Major Depressive Disorder: Findings From the ENIGMA Major Depressive Disorder Consortium. Journal Of Psychopathology And Clinical Science. 2022; 131(6)DOI:10.1037/abn0000738. PMID:35653754. IF:(Q/D).

Martinez-Amoros, E, Serra, P, Bassa, A, Palao, DJ, Cardoner, N. Discontinuation of maintenance electroconvulsive therapy: Lessons learned from the COVID-19 pandemic. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(2)DOI:10.1016/j.rpsm.2021.07.005. PMID:34329756. IF:9.200(Q1/1D).

Aragones, E, Lopez-Cortacans, G, Cardoner, N, Tome-Pires, C, Porta-Casteras, D, Palao, D. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-022-07872-z. PMID:35382822. IF:2.800(Q3/6D).

Soler J., Casellas-Pujol E., Pascual J.C., Schmidt C., Domínguez-Clavé E., Cebolla A., Alvear D., Muro A., Elices M.. Advancing the treatment of long-lasting borderline personality disorder: a feasibility and acceptability study of an expanded DBT-based skills intervention. Borderline Personality Disorder and Emotion Dysregulation. 2022; 9(1)DOI:10.1186/s40479-022-00204-x. PMID:36503564. IF:4.100(Q2/5D).

Segura À.-G., Prohens L., Mezquida G., Amoretti S., Bioque M., Ribeiro M., Gurriarán-Bas X., Rementería L., Berge D., Rodriguez-Jimenez R., Roldán A., Pomarol-Clotet E., Ibáñez A., Usall J., García-Portilla M.P., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., González-Díaz J.M., Arbelo N., González-Peñas J., Pina-Camacho L., Diestre A., Selma J., Zorrilla I., López P., Trabsa A., Monserrat C., Sanchez-Pastor L., Nuñez-Doyle A., Fatjó-Vilas M., Sarró S., Butjosa A., Pardo M., López-Ilundain J.M., Sánchez Torres A.M., Saiz-Ruiz J., Ochoa-Mangado E., RIevero O., De-la-Cámara C., Echevarría R.S., González-Blanco L.. Epigenetic clocks in relapse after a first episode of schizophrenia. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00268-2. PMID:35869075. IF:5.400(Q2/3D).

Garcia-Rizo C., Cabrera B., Bioque M., Mezquida G., Lobo A., Gonzalez-Pinto A., Diaz-Caneja C.M., Corripio I., Vieta E., Baeza I., Garcia-Portilla M.P., Gutierrez-Fraile M., Rodriguez-Jimenez R., Garriga M., Fernandez-Egea E., Bernardo M.. The effect of early life events on glucose levels in first-episode psychosis. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.983792. PMID:36545332. IF:5.200(Q1/3D).

Pujol N., Bergé D., Mané A., Bioque M., Mezquida G., Amoretti S., Baeza I., González-Pinto A., Lobo A., Cuesta M.J., Ribeiro M., Sánchez-Tomico G., Pérez-Solà V., Verdolini N., Vieta E., Parellada M., Roldán A., Bernardo M.. The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study. PSYCHIATRY RESEARCH. 2022; 316DOI:10.1016/j.psychres.2022.114760. PMID:35977447. IF:11.300(Q1/1D).

Rodríguez-Toscano E., Martínez K., Fraguas D., Janssen J., Pina-Camacho L., Arias B., Vieta E., Mezquida G., Amoretti S., Bernardo M., Castro-Fornieles J., Cuesta-Zorita M.J., Lobo A., González-Pinto A., Collado I.C., Mané A., Arango C., Parellada M.. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(2)DOI:10.1016/j.rpsm.2021.11.002. PMID:35840287. IF:9.200(Q1/1D).

Kong X.-Z., Mathias S.R., Guadalupe T., Abé C., Akudjedu T.N., Aleman A., Alhusaini S., Allen N.B., Ames D., Andreassen O.A., Vasquez A.A., Armstrong N.J., Asherson P., Bergo F., Bastin M.E., Batalla A., Bauer J., Baune B.T., Baur-Streubel R., Biederman J., Blaine S.K., Boedhoe P., Bøen E., Bose A., Bralten J., Brandeis D., Brem S., Brodaty H., Yüksel D., Brooks S.J., Buitelaar J., Bürger C., Bülow R., Calhoun V., Calvo A., Canales-Rodríguez E.J., Cannon D.M., Caparelli E.C., Castellanos F.X., Cendes F., Chaim-Avancini T.M., Chantiluke K., Chen Q.-L., Chen X., Cheng Y., Christakou A., Clark V.P., Coghill D., Connolly C.G., Conzelmann A., Córdova-Palomera A., Cousijn J., Crow T., Cubillo A., Dannlowski U., de Bruttopilo S.A., de Zeeuw P., Deary I.J., Demeter D.V., Di Martino A., Dickie E.W., Dietsche B., Doan N.T., Doherty C.P., Doyle A., Durston S., Earl E., Ehrlich S., Ekman C.J., Elvsåshagen T., Epstein J.N., Fair D.A., Faraone S.V., Fernández G., Flint C., Filho G.B., Förster K., Fouche J.-P., Foxe J.J., Frodl T., Fuentes-Claramonte P., Fullerton J.M., Garavan H., do Santos Garcia D., Gotlib I.H., Goudriaan A.E., Grabe H.J., Groenewold N.A., Grotegerd D., Gruber O., Gurholt T., Haavik J., Hahn T., Hansell N.K., Harris M.A., Hartman C.A., del Carmen Valdés Hernández M., Heslenfeld D., Hester R., Hibar D.P., Ho B.-C., Ho T.C., Hoekstra P.J., van Holst R.J., Hoogman M., Høvik M.F., Howells F.M., Hugdahl K., Huyser C., Ingvar M., Ishikawa A., James A., Jahanshad N., Jernigan T.L., Jönsson E.G., Kaleda V., Kelly C., Kerich M., Keshavan M.S., Khadka S., Kircher T., Kohls G., Konrad K., Korucuoglu O., Krämer B., Krug A., Kuntsi J., Kwon J.S., Lambregts-Rommelse N., Landén M., Lázaro L., Lebedeva I., Lenroot R., Lesch K.-P., Li Q., Lim K.O., Liu J., Lochner C., London E.D., Lorenzetti V., Luciano M., Luijten M., Lundervold A.J., Mackey S., MacMaster F.P., Maingault S., Malpas C.B., Malt U.F., Mataix-Cols D., Martin-Santos R., Mayer A.R., McCarthy H., Medland S., Metha M., Mitchell P.B., Mueller B.A., Maniega S.M., Mazoyer B., McDonald C., McLellan Q., McMahon K.L., McPhilemy G., Momenan R., Morales A.M., Narayanaswamy J.C., Moreira J.C.V., Nerland S., Nestor L., Newman E., Nigg J.T., Nordvik J.E., Novotny S., Weiss E.O., O'Gorman R.L., Oosterlaan J., Oranje B., Orr C., Overs B., Paloyelis Y., Pauli P., Paulus M., Plessen K.J., von Polier G.G., Pomarol-Clotet E., Portella M.J., Qiu J., Radua J., Ramos-Quiroga J.A., Reddy Y.C.J., Reif A., Roberts G., Rosa P., Rubia K., Sacchet M.D., Sachdev P.S., Salvador R., Schmaal L., Schulte-Rüther M., Schweren L., Seitz J., Serpa M.H., Shaw P., Shumskaya E., Silk T.J., Simmons A.N., Simulionyte E., Sinha R., Sjoerds Z., Smelror R.E., Soliva J.C., Solowij N., Souza-Duran F.L., Sponheim S.R., Stein D.J., Stein E.A., Stevens M., Strike L.T., Sudre G., Sui J., Tamm L., Temmingh H.S., Thoma R.J., Tomyshev A., Tronchin G., Turner J., Uhlmann A., van Erp T.G.M., van den Heuvel O.A., van der Meer D., van Eijk L., Vance A., Veer I.M., Veltman D.J., Venkatasubramanian G., Vilarroya O., Vives-Gilabert Y., Voineskos A.N., Völzke H., Vuletic D., Walitza S., Walter H., Walton E., Wardlaw J.M., Wen W., Westlye L.T., Whelan C.D., White T., Wiers R.W., Wright M.J., Wittfeld K., Yang T.T., Yasuda C.L., Yoncheva Y., Yücel M., Yun J.-Y., Zanetti M.V., Zhen Z., Zhu X.-X., Ziegler G.C., de Zubicaray G.I., Zwiers M., Glahn D.C., Crivello F., Fisher S.E., Thompson P.M., Francks C., Farde L., Flyckt L., Engberg G., Erhardt S., Fatouros-Bergman H., Cervenka S., Schwieler L., Piehl F., Agartz I., Collste K., Victorsson P., Malmqvist A., Hedberg M., Orhan F., Sellgren C.. Reproducibility in the absence of selective reporting: An illustration from large-scale brain asymmetry research. HUMAN BRAIN MAPPING. 2022; 43(1)DOI:10.1002/hbm.25154. PMID:32841457. IF:4.800(Q1/2D).

Han, LKM, Dinga, R, Hahn, T, Ching, CRK, Eyler, LT, Aftanas, L, Aghajani, M, Aleman, A, Baune, BT, Berger, K, Brak, I, Filho, GB, Carballedo, A, Connolly, CG, Couvy-Duchesne, B, Cullen, KR, Dannlowski, U, Davey, CG, Dima, D, Duran, FLS, Enneking, V, Filimonova, E, Frenzel, S, Frodl, T, Fu, CHY, Godlewska, BR, Gotlib, IH, Grabe, HJ, Groenewold, NA, Grotegerd, D, Gruber, O, Hall, GB, Harrison, BJ, Hatton, SN, Hermesdorf, M, Hickie, IB, Ho, TC, Hosten, N, Jansen, A, Kahler, C, Kircher, T, Klimes-Dougan, B, Kramer, B, Krug, A, Lagopoulos, J, Leenings, R, MacMaster, FP, MacQueen, G, McIntosh, A, McLellan, Q, McMahon, KL, Medland, SE, Mueller, BA, Mwangi, B, Osipov, E, Portella, MJ, Pozzi, E, Reneman, L, Repple, J, Rosa, PGP, Sacchet, MD, Samann, PG, Schnell, K, Schrantee, A, Simulionyte, E, Soares, JC, Sommer, J, Stein, DJ, Steinstrater, O, Strike, LT, Thomopoulos, IT, van Tol, MJ, Veer, IM, Vermeiren, RRJM, Walter, H, van der Wee, NJA, van der Werff, SJA, Whalley, H, Winter, NR, Wittfeld, K, Wright, MJ, Wu, MJ, Volzke, H, Yang, TT, Zannias, V, de Zubicaray, GI, Zunta-Soares, GB, Abe, C, Alda, M, Andreassen, OA, Boen, E, Bonnin, CM, Canales-Rodriguez, EJ, Cannon, D, Caseras, X, Chaim-Avancini, TM, Elvsashagen, T, Favre, P, Foley, SF, Fullerton, JM, Goikolea, JM, Haarman, BCM, Hajek, T, Henry, C, Houenou, J, Howells, FM, Ingvar, M, Kuplicki, R, Lafer, B, Landen, M, Machado-Vieira, R, Malt, UF, McDonald, C, Mitchell, PB, Nabulsi, L, Otaduy, MCG, Overs, BJ, Polosan, M, Pomarol-Clotet, E, Radua, J, Rive, MM, Roberts, G, Ruhe, HG, Salvador, R, Sarro, S, Theodore, DS, Savitz, J, Schene, AH, Schofield, PR, Serpa, MH, Sim, K, Soeiro-de-Souza, MG, Sutherland, AN, Temmingh, HS, Timmons, GM, Uhlmann, A, Vieta, E, Wolf, DH, Zanetti, MV, Jahanshad, N, Thompson, PM, Veltman, DJ, Penninx, BWJH, Marquand, AF, Cole, JH, Schmaal, L. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. MOLECULAR PSYCHIATRY. 2021; 26(9)DOI:10.1038/s41380-020-0754-0. PMID:32424236. IF:13.437(Q1/1D).

Arqueros, M, Soler, J, Schmidt, C, Vega, D, Pascual, JC. Could intranasal oxytocin enhance the effects of psychotherapy in individuals with mental disorders? A systematic review and meta-analysis (vol 171, 107206 , 2025). PSYCHONEUROENDOCRINOLOGY. 2025; 182DOI:10.1016/j.psyneuen.2025.107623. PMID:41061382. IF:3.600(Q1/3D).

Verdaguer-Rodríguez, M, López-Carrilero, R, Díaz-Cutraro, L, Ferrer-Quintero, M, Grasa, E, Pousa, E, Lorente-Rovira, E, Birulés, I, Peláez, T, Barrigón, ML, Ruiz-Delgado, I, González-Higueras, F, Cid, J, Gutiérrez-Zotes, A, Barajas, A, Ochoa, S. Sex-based differences in neurocognitive functioning in first-episode psychosis: An exploratory analysis. PSYCHIATRY RESEARCH. 2025; 354DOI:10.1016/j.psychres.2025.116803. PMID:41167092. IF:3.900(Q1/2D).

Serrarens, C, Toenders, YJ, Pozzi, E, Aleman, A, Alexander, N, Basgöze, Z, Belov, V, Berger, K, Brosch, K, Bülow, R, Busatto, GF, Capitao, LP, Connolly, CG, Couvy-Duchesne, B, Cullen, KR, Dannlowski, U, Davey, CG, De Zubicaray, GI, Dima, D, Dohm, K, Enneking, V, Erwin-Grabner, T, Evermann, U, Fu, CHY, Fuentes-Claramonte, P, Godlewska, BR, Gonul, AS, Gotlib, IH, Goya-Maldonado, R, Grabe, HJ, Groenewold, NA, Grotegerd, D, Gruber, O, Hahn, T, Hall, G, Harrison, B, Heindel, W, Hermesdorf, M, Ho, TC, Ichikawa, N, Itai, E, Jahanshad, N, Jamalabadi, H, Jamieson, AJ, Jansen, A, Kircher, T, Klimes-Dougan, B, Krämer, B, Krug, A, Lancaster, TM, Leehr, EJ, Li, M, Linden, DEJ, MacMaster, F, McMahon, KL, Medland, SE, Mehler, DMA, Meinert, S, Mwangi, B, Nenadic, I, Okada, G, Okamoto, Y, Opel, N, Pfarr, JK, Pomarol-Clotet, E, Portella, MJ, Redlich, R, Reneman, L, Repple, J, Ringwald, K, Rodriguez-Cano, E, Rosa, PGP, Sacchet, MD, Sämann, PG, Salvador, R, Schrantee, A, Shinzato, H, Sim, K, Simulionyte, E, Soares, JC, Stein, DJ, Stein, F, Straube, B, Strike, LT, Thomas-Odenthal, F, Thomopoulos, SI, Thompson, PM, Van Tol, MJ, Usemann, P, Uyar, A, van der Wee, N, van der Werff, S, Vives-Gilabert, Y, Völzke, H, Walter, M, Whittle, S, Wittfeld, K, Wroblewski, A, Wu, MJ, Yang, TT, Zunta-Soares, GB, Veltman, DJ, Schmaal, L, van Velzen, LS. Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group. MOLECULAR PSYCHIATRY. 2025; 30(12)DOI:10.1038/s41380-025-03310-8. PMID:41184571. IF:10.100(Q1/1D).

Lamarca, M, Romero-Castillejo, A, Balsells-Mejia, S, Lopez-Carrilero, R, Vila-Badia, R, Pousa, E, Grasa, E, Barrigon, M, Birulés, I, Peláez, T, Gutiérrez-Zotes, A, Cabezas, A, Lorente-Rovira, E, Cid, J, Ruiz-Delgado, I, González-Higueras, F, Legido, T, Moreno-Küstner, B, Barajas, A, Ochoa, S. The Role of Sex, Quality of Life, Self-Esteem and Cognitive Insight in Reducing Personal Stigma in Psychosis. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2025; 32(6)DOI:10.1002/cpp.70171. PMID:41215569. IF:2.700(Q2/3D).

Romero-Castillejo, A, López-Carrilero, R, Vila-Badia, R, Lamarca, M, Pousa, E, Grasa, E, Barajas, A, Barrigon, ML, Birules, I, Peláez, T, Gutiérrez-Zotes, A, Lorente-Rovira, E, Cid, J, Ruiz-Delgado, I, Gonzalez-Higueras, F, Legido, T, Moreno-Küstner, B, Moritz, S, Ochoa, S. The Influence of Metacognition, Social Cognition, Self-Esteem, and Quality of Life on Personal Stigma in First-Episode Psychosis. Stigma And Health. 2025; 10(4)DOI:10.1037/sah0000513. PMID:. IF:(Q/D).

Segura, AG, Verdolini, N, Valli, I, Garcia-Rizo, C, Diaz-Caneja, CM, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldan, A, Martinez-Aran, A, Baeza, I, Mane, A, Labad, J, Müller, DJ, Guasch-Capella, N, Bernardo, M, Mas, S, Bioque, GM, Gonzalez, J, Andrés, P, Cavone, V, Corripio, I, Duque, A, Mar-Barrutia, L, Marin, J, De-la-Camara, C, Vaquero-Puyuelo, D, Rivero, O, Fabra, MJE, Trabsa, A, Legido, T, Forte, MF, Serra-Navarro, M, de la Serna, H, Castro-Fornielles, J, Contreras, F, García-Portilla, MP, González-Blanco, L, Echevarría, RS, Rabadán, AZ, Rodriguez-Jimenez, R, Martínez-Gras, I, Usall, J, Barajas, A, Sarro, S, Pomarol-Clotet, E, Ibañez, A, Cuesta, MJ. Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis. SCHIZOPHRENIA RESEARCH. 2025; 285DOI:10.1016/j.schres.2025.09.019. PMID:41075679. IF:3.500(Q1/3D).

Pérez, V, Puigdemont, D, de Diego-Adeliño, J, Elices, M, Leal, I, Cabello, M, Rodriguez-Jimenez, R, Alvarez-Mon, MA, García-Fernández, L, García-Iturrospe, EJA, Escartí, MJ, Montejo, AL, Montes, JM, Usall, J, Gallego-Nogueras, A, Lujan, E, López-Carrilero, R, González-Pinto, A, Ortiz-Jauregui, A, Blanch, J, Urretavizcaya, M, Colom, F, García-Campayo, J, Ayuso-Mateos, JL. The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment. BRITISH JOURNAL OF PSYCHIATRY. 2025; 227(5)DOI:10.1192/bjp.2025.13. PMID:40530754. IF:7.600(Q1/1D).